Prime Minister summarizes state of the nation

Prime Minister Erna Solberg held an annual press conference at her residence in Parkveien in Oslo on Wednesday, where she summarized the past year and the state of the nation.

BionorPharma Presentation at DNB Markets Nordic Health Care Conference 27 November 2013

The Company presented update of the clinical development program with three HIV vaccine studies reading out in 2014, and the planned study combining the HIV vaccine Vacc-4x with the reservoir purging agent Romidepsin, so called HDAC inhibitor, aiming towards a functional cure for HIV. See the presentation here or visit the BionorPharma website here.

Bionor Pharma ASA – Successful completion of subsequent offering

Reference is made to the prospectus dated 7 October 2013 and the stock exchange announcement dated 8 October 2013 concerning the subsequent offering (the “Subsequent Offering”) of up to 7,500,000 shares (the “Offer Shares”) in Bionor Pharma ASA (the “Company”) at a subscription price of NOK 2.75 per share. The Company reports that the Subsequent Offering was oversubscribed.

Winner of Swiss consumer test

– For years already, we have been recommending the Active Walker. It stands out positively due to its functionality, stability and comfort. If you have once chosen the Active, you will never again want to change it for another model, says Markus Joho, manager of the Swiss company Kuhn und Bieri AG which distributes Active in Switzerland.

Bionor Pharma Featured in Positiv Magazine, From the AIDS Conference in Kuala Lumpur

Oslo 16.09.2013 – The CEO of Bionor Pharma, Anker Lundemose is interviewed in this article about the AIDS conference in Kuala Lumpur July 2013. Dr. Lundemose emphasizes the Danish HIV research aiming at emptying the HIV reservoirs in the body, which potentially can contribute to a Functional Cure for HIV HivNorge is a Norwegian organization […]